Skip to content

Evaluation of effect of coenzyme q10 and aerobic exercise on inflammatory, oxidative state and cardiorespiratory fitness in patients with traumatic brain injury

Evaluation of effect of coenzyme q10 and aerobic exercise on inflammatory, oxidative state and cardiorespiratory fitness in patients with traumatic brain injury

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017071626805N2
Enrollment
60
Registered
2017-11-19
Start date
2018-02-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

traumatic brain injury. Intracranial injury

Interventions

Intervention 1: Control group: with no intervention. Intervention 2: Intervention group: the intervention group will receive 2.5 mg/kg/day Coenzyme Q10 for 3 months and they will do exercise 60-90 min
Treatment - Drugs
Control group: with no intervention.
Intervention group: the intervention group will receive 2.5 mg/kg/day Coenzyme Q10 for 3 months and they will do exercise 60-90 minutes, three times a week for 12 weeks.

Sponsors

Vice Chancellor for research of Ilam University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: History of Traumatic Brain Injury 6 months ago; 18-65 years old; Stable clinical situation; Having a medical certificate proving participants’ ability to do exercise test; Commitment to complete the study; Ability to understand speech commands to complete study and ability to cycling to do exercise. Exclusion criteria: Severe behavioral, physical and cognitive status preventing completing the study; chronic and systemic disease(cardiovascular, pulmonary...); Failure to cooperate until the end of the study; smoking and Drug addiction.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
IL-6. Timepoint: before intervention and 6th week and 12th week after begining of intervention. Method of measurement: The IL-6 will be measured by ELISA method and by the bender medsystem kit.;Cardiac function. Timepoint: before intervention and 6th week and 12th week after begining of intervention. Method of measurement: Cardiac function will be tested with Bruce protocol.;Respiratory gasses. Timepoint: before intervention and 6th week and 12th week after begining of intervention. Method of measurement: respiratory gases automaticly will be analyzed using Ultima CardiO2.;Hs-CRP. Timepoint: before intervention and 6th week and 12th week after begining of intervention. Method of measurement: hs-CRP will be measured by ELISA method and by the bender medsystem kit.;Malondialdehyde. Timepoint: before intervention and 6th week and 12th week after begining of intervention. Method of measurement: Levels of malondialdehyde will be measured by the Randox kit.;Total antioxidant capacity. Timepoint: before intervention and 6th week and 12th week after begining of intervention. Method of measurement: total antioxidant capacity will be measured by the Randox kit.;Glutathione peroxidase. Timepoint: before intervention and 6th week and 12th week after begining of intervention. Method of measurement: glutathione peroxidase will be measured by the Randox kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAsghar Rahmani

Ilam University of Medical Sciences

Asrahmani1991@yahoo.com+98 84 3222 7126

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026